These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16356026)

  • 1. Pharmacotherapy of hyperlipidemia in pediatric heart transplant recipients: current practice and future directions.
    Chin C; Bernstein D
    Paediatr Drugs; 2005; 7(6):391-6. PubMed ID: 16356026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for minimizing hyperlipidemia after cardiac transplantation.
    Kirklin JK; Benza RL; Rayburn BK; McGiffin DC
    Am J Cardiovasc Drugs; 2002; 2(6):377-87. PubMed ID: 14727953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft vessel disease following heart transplantation: a systematic review of the role of statin therapy.
    Som R; Morris PJ; Knight SR
    World J Surg; 2014 Sep; 38(9):2324-34. PubMed ID: 24700094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How much do we really know about statins and transplant vasculopathy?
    Harken AH
    World J Surg; 2014 Sep; 38(9):2335-6. PubMed ID: 24844656
    [No Abstract]   [Full Text] [Related]  

  • 5. Current and future treatment of hyperlipidemia: the role of statins.
    Farnier M; Davignon J
    Am J Cardiol; 1998 Aug; 82(4B):3J-10J. PubMed ID: 9737640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hyperlipidemia in cardiac transplant recipients.
    Bilchick KC; Henrikson CA; Skojec D; Kasper EK; Blumenthal RS
    Am Heart J; 2004 Aug; 148(2):200-10. PubMed ID: 15308989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of pediatric graft coronary artery disease: atorvastatin.
    Chin C; Lukito SS; Shek J; Bernstein D; Perry SB
    Pediatr Transplant; 2008 Jun; 12(4):442-6. PubMed ID: 18466431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Statins (HMG-CoA reductase inhibitors)].
    Gotoda T
    Nihon Rinsho; 2006 Nov; 64(11):2113-8. PubMed ID: 17087305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transplant coronary artery disease--treatment with statins].
    Wolszakiewicz J; Bilińska M
    Pol Merkur Lekarski; 2004 May; 16(95):472-3. PubMed ID: 15518430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives in the treatment of dyslipidemias in the prevention of coronary heart disease.
    Borgia MC; Medici F
    Angiology; 1998 May; 49(5):339-48. PubMed ID: 9591525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperlipidemia in children after heart transplantation.
    Singh TP; Naftel DC; Webber S; Dupuis J; Chin C; Spicer R; Schowengerdt KO; Ring WS; Morrow WR;
    J Heart Lung Transplant; 2006 Oct; 25(10):1199-205. PubMed ID: 17045932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaches to the treatment of hyperlipidemia in the solid organ transplant recipient.
    Kirk JK; Dupuis RE
    Ann Pharmacother; 1995 Sep; 29(9):879-91. PubMed ID: 8547738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein abnormalities are highly prevalent in pediatric heart transplant recipients.
    Chin C; Rosenthal D; Bernstein D
    Pediatr Transplant; 2000 Aug; 4(3):193-9. PubMed ID: 10933319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should pediatric patients with hyperlipidemia receive drug therapy?
    Bhatnagar D
    Paediatr Drugs; 2002; 4(4):223-30. PubMed ID: 11960511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins in coronary artery bypass grafting surgery: lipid lowering and beyond.
    Margaritis M; Antoniades C
    Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):5-8. PubMed ID: 22149521
    [No Abstract]   [Full Text] [Related]  

  • 17. Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia.
    Goa KL; Barradell LB; Plosker GL
    Drugs; 1996 Nov; 52(5):725-53. PubMed ID: 9118820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperlipidemia after cardiac transplantation: be aware and possibly wary of drug therapy for lowering of serum lipids.
    Butman SM
    Am Heart J; 1991 May; 121(5):1585-90. PubMed ID: 2018001
    [No Abstract]   [Full Text] [Related]  

  • 19. Dyslipidemias and HMG-CoA reductase inhibitor prescription in heart transplant recipients.
    de Denus S; Al-Jazairi A; Loh E; Jessup M; Stanek EJ; Spinler SA
    Ann Pharmacother; 2004; 38(7-8):1136-41. PubMed ID: 15150383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hyperlipidaemia associated with heart transplantation.
    Wenke K
    Drugs; 2004; 64(10):1053-68. PubMed ID: 15139786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.